FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.027
EU - Europa 20.237
AS - Asia 15.813
SA - Sud America 2.238
AF - Africa 415
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 27
Totale 73.804
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.570
GB - Regno Unito 6.628
SG - Singapore 4.496
CN - Cina 4.460
IT - Italia 4.299
SE - Svezia 3.764
HK - Hong Kong 2.072
BR - Brasile 1.682
VN - Vietnam 1.668
DE - Germania 1.139
TR - Turchia 810
UA - Ucraina 801
FI - Finlandia 735
RU - Federazione Russa 709
FR - Francia 673
KR - Corea 536
IN - India 405
BG - Bulgaria 314
NL - Olanda 201
CA - Canada 188
AR - Argentina 176
BD - Bangladesh 169
MX - Messico 157
JP - Giappone 154
RO - Romania 151
IQ - Iraq 143
ZA - Sudafrica 129
ID - Indonesia 127
IE - Irlanda 126
ES - Italia 112
PL - Polonia 109
PK - Pakistan 98
BE - Belgio 93
AE - Emirati Arabi Uniti 87
EC - Ecuador 87
CO - Colombia 84
CH - Svizzera 66
MY - Malesia 64
TH - Thailandia 60
VE - Venezuela 58
MA - Marocco 57
CL - Cile 56
IR - Iran 50
DZ - Algeria 48
EG - Egitto 46
LT - Lituania 45
PH - Filippine 42
UZ - Uzbekistan 42
SA - Arabia Saudita 40
AU - Australia 39
CZ - Repubblica Ceca 36
IL - Israele 36
PT - Portogallo 36
JO - Giordania 35
NP - Nepal 35
PE - Perù 34
TN - Tunisia 34
PY - Paraguay 30
AT - Austria 28
KE - Kenya 27
TW - Taiwan 26
AZ - Azerbaigian 25
GR - Grecia 23
EU - Europa 20
KZ - Kazakistan 20
SN - Senegal 19
DO - Repubblica Dominicana 17
ET - Etiopia 17
MD - Moldavia 17
BO - Bolivia 16
DK - Danimarca 16
JM - Giamaica 16
AL - Albania 14
UY - Uruguay 14
LB - Libano 13
OM - Oman 13
RS - Serbia 12
TT - Trinidad e Tobago 12
BY - Bielorussia 11
CR - Costa Rica 11
HU - Ungheria 11
LV - Lettonia 10
NO - Norvegia 10
PA - Panama 10
KG - Kirghizistan 9
EE - Estonia 8
GT - Guatemala 8
HR - Croazia 8
NZ - Nuova Zelanda 8
BH - Bahrain 7
CY - Cipro 7
HN - Honduras 7
PS - Palestinian Territory 7
SI - Slovenia 7
AM - Armenia 6
AO - Angola 6
KH - Cambogia 6
LK - Sri Lanka 6
LU - Lussemburgo 6
MN - Mongolia 6
Totale 73.681
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Santa Clara 3.343
Ashburn 3.002
Singapore 2.845
Fairfield 2.617
Chandler 2.172
Hong Kong 2.035
Woodbridge 1.903
Stockholm 1.816
Jacksonville 1.618
Hefei 1.443
Houston 1.318
Chicago 1.253
Dearborn 1.215
Wilmington 1.107
Seattle 1.068
Nyköping 1.060
Ann Arbor 1.049
San Jose 960
Cambridge 880
Beijing 871
London 735
Los Angeles 733
Ho Chi Minh City 542
Modena 485
Izmir 465
Seoul 456
Helsinki 441
The Dalles 435
Council Bluffs 399
Hanoi 397
Salt Lake City 336
Princeton 324
New York 304
Sofia 301
Eugene 275
Milan 255
Des Moines 247
San Diego 237
Lauterbourg 231
Dallas 222
Buffalo 200
Rome 199
Moscow 182
Redwood City 180
Shanghai 153
São Paulo 147
Bremen 146
Tampa 142
Elk Grove Village 135
Orem 132
Munich 118
Tokyo 115
Dublin 105
Fremont 104
Columbus 98
Boardman 93
Bologna 93
Frankfurt am Main 93
Chennai 86
Brussels 80
Naples 77
Falls Church 76
Guangzhou 76
Lancaster 75
Phoenix 72
Jakarta 70
Da Nang 69
Sterling 65
Haiphong 62
Johannesburg 62
Warsaw 61
Miami 57
Parma 56
Norwalk 54
Brooklyn 52
Washington 52
Atlanta 50
Baghdad 50
Denver 50
Florence 50
Como 49
Nanjing 48
Dulles 47
Amsterdam 46
Turin 46
Kunming 45
Montreal 43
Rio de Janeiro 43
Detroit 42
Reggio Emilia 42
Toronto 42
Belo Horizonte 40
Bari 39
Mexico City 39
Mumbai 39
Napoli 39
Redondo Beach 38
Quito 37
New Delhi 36
Totale 51.252
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.290
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 570
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 501
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 484
Cristallinità ed equivalenza nel cloramfenicolo palmitato 469
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 464
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 456
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 447
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 446
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 432
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 420
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 418
Cationic liposomes for gene transfection 417
NUTRASCIENCE s.r.l. 416
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 411
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 410
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 408
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 408
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 408
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 397
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 392
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 392
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 392
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 383
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 383
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 379
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 379
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 371
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 364
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 362
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 360
Polymeric nanoparticles for the drug delivery to the central nervous system 358
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 357
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 356
Distribution of drugs in polymers loaded by swelling 355
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 353
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 351
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 350
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 345
Protein corona and nanoparticles: How can we investigate on? 344
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 343
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 341
Microwave-treated gelatin microspheres as drug delivery system 340
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 339
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 339
Nanoparticle transport across the blood brain barrier 338
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 337
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 337
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 336
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 325
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 325
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 324
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 324
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 324
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 323
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 323
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 321
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 320
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 319
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 318
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 318
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 317
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 315
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 315
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 314
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 311
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 310
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 308
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 308
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 305
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 301
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 301
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 301
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 300
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 299
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 299
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 298
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 298
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 296
Colloidal systems for CNS drug delivery 295
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 295
Functionalization of liposomes: microscopical methods for preformulative screening 294
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 294
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 293
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 291
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 290
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 289
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 289
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 289
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 286
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 285
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 285
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 284
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 282
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 279
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 279
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 275
Papaverine hydrochloride release from ethyl cellulose-walled microcapsules 275
1H and 13C NMR Study on the Interaction between Diclofenac and 2-Hydroxypropyl-beta-Cyclodextrin 275
Totale 36.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 257.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.860 0 0 0 0 0 0 0 0 0 1.076 442 342
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202621.856 1.437 785 1.782 2.776 4.171 1.590 2.383 1.060 4.114 1.758 0 0
Totale 74.245